KIRSKE DAVID sold XFOR
October 1, 2026 · Form 4 insider transaction
KIRSKE DAVID sold 11,767 shares of X4 Pharmaceuticals, Inc. at $2.86 per share, a transaction worth $33.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $2.82 to $2.92, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; Of the shares of common stock reported, 64,418 shares represent restricted stock units.